Cargando…
Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
Comprehensive genomic profiling examinations (CGPs) have recently been developed, and a variety of tumor-agnostic mutations have been detected, leading to the development of new molecular-targetable therapies across solid tumors. In addition, the elucidation of hereditary tumors, such as breast and...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775249/ https://www.ncbi.nlm.nih.gov/pubmed/36551764 http://dx.doi.org/10.3390/biomedicines10123008 |